Duality Advisers, LP Nektar Therapeutics Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$3.17 - $6.17 $1.09 Million - $2.11 Million	-342,369 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$4.16 - $13.72 $1.42 Million - $4.7 Million	342,369 New	342,369 $1.85 Million
Q3 2020 Nov 12, 2020	SELL	$16.59 - $24.79 $2.07 Million - $3.09 Million	-124,626 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$16.86 - $23.44 $2.1 Million - $2.92 Million	124,626 New	124,626 $2.89 Million
Q1 2020 May 06, 2020	SELL	$14.47 - $27.96 $3.97 Million - $7.67 Million	-274,272 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$15.87 - $23.12 $4.35 Million - $6.34 Million	274,272 New	274,272 $5.92 Million

153

131M

92.7K

4.9K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $150M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.